XBiotech Inc.
XBIT
$8.54
$0.111.31%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 25.36% | 36.06% | -6.17% | -54.74% | -88.93% |
| Total Depreciation and Amortization | -33.28% | -38.98% | -27.28% | -14.25% | -1.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.59% | -100.90% | -39.06% | 35.40% | 76.16% |
| Change in Net Operating Assets | -64.22% | -65.03% | 129.89% | -89.70% | -90.47% |
| Cash from Operations | -26.32% | -37.54% | -15.62% | -123.21% | -121.35% |
| Capital Expenditure | 38.12% | 59.20% | 60.82% | 85.90% | 83.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 197.71% | 197.57% | -- | -- | -- |
| Cash from Investing | 196.25% | 195.44% | -4,400.56% | -1,990.42% | -1,712.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -84.85% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -127.27% | 99.98% | -- | -- |
| Foreign Exchange rate Adjustments | 95.21% | 153.41% | -10.03% | -314.76% | -236.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 153.61% | 153.15% | 7.89% | -884.57% | -20,703.39% |
